Biohaven Ltd. financial data

Symbol
BHVN on NYSE
Industry
Pharmaceutical Preparations
Location
215 Church Street, New Haven, CT
State of incorporation
Virgin Islands, British
Fiscal year end
December 31
Former names
Biohaven Research Ltd. (to 9/14/2022)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 448 % -12.9%
Debt-to-equity 35.2 % +24.4%
Return On Equity -213 % -85.1%
Return On Assets -157 % -75.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 94.5M shares +38.4%
Common Stock, Shares, Outstanding 92.3M shares +35.2%
Entity Public Float 987M USD
Common Stock, Value, Issued 1.3B USD +110%
Weighted Average Number of Shares Outstanding, Basic 87.8M shares +28.6%
Weighted Average Number of Shares Outstanding, Diluted 87.8M shares +28.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 701M USD +111%
General and Administrative Expense 80.1M USD -33.2%
Costs and Expenses 781M USD +72.5%
Operating Income (Loss) -781M USD -72.5%
Nonoperating Income (Expense) 14.2M USD +143%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -750M USD -70.3%
Income Tax Expense (Benefit) -3.75M USD +61.7%
Net Income (Loss) Attributable to Parent -747M USD -73.3%
Earnings Per Share, Basic -9.22 USD/shares -23.3%
Earnings Per Share, Diluted -9.22 USD/shares -23.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 239M USD +62%
Marketable Securities, Current 198M USD +5.49%
Other Assets, Current 7.27M USD -67.4%
Assets, Current 511M USD +17.8%
Property, Plant and Equipment, Net 18.7M USD +8.03%
Operating Lease, Right-of-Use Asset 29.9M USD -9.93%
Intangible Assets, Net (Excluding Goodwill) 18.4M USD 0%
Goodwill 1.39M USD 0%
Other Assets, Noncurrent 32.9M USD -7.41%
Assets 583M USD +15%
Accounts Payable, Current 17.3M USD +43.4%
Employee-related Liabilities, Current 10.8M USD +17.5%
Accrued Liabilities, Current 57.7M USD +63.1%
Liabilities, Current 156M USD +77.8%
Operating Lease, Liability, Noncurrent 26.2M USD -10%
Other Liabilities, Noncurrent 4.32M USD +71.5%
Liabilities 199M USD +66.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -78K USD -490%
Retained Earnings (Accumulated Deficit) -999M USD -296%
Stockholders' Equity Attributable to Parent 384M USD -0.91%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 539M USD +1453%
Liabilities and Equity 583M USD +15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -103M USD -32.2%
Net Cash Provided by (Used in) Financing Activities 3.42M USD -87.2%
Net Cash Provided by (Used in) Investing Activities 34M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 92.3M shares +35.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.2M USD -25.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 242M USD +20%
Deferred Tax Assets, Valuation Allowance 259M USD +20.1%
Operating Lease, Liability 30.9M USD -8.1%
Depreciation 3.72M USD +52.8%
Payments to Acquire Property, Plant, and Equipment 440K USD -40.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747M USD -73.3%
Lessee, Operating Lease, Liability, to be Paid 39.8M USD -10.8%
Operating Lease, Liability, Current 3.55M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78M USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.02M USD +1.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.9M USD -18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.91M USD +3.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.2M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.51M USD -7.32%
Additional Paid in Capital 83.8M USD +287%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.45M USD -12.3%
Deferred Tax Assets, Net of Valuation Allowance 7.52M USD +1061%